Statistical validation of a new helical tomotherapy patient transfer station.

J Appl Clin Med Phys

Department of Radiation Oncology, City of Hope Cancer Center, Duarte, California, USA.

Published: June 2009

AI Article Synopsis

  • This study evaluates the accuracy of a Patient Transfer Station (PTS) that automatically converts treatment plans for patients moving between two tomotherapy systems in a medical department.
  • Thirty patients were analyzed, comparing dose differences between their original plans and those transferred via PTS, revealing an average dose difference of 0.8% with maximum deviations of 1.9% and 2.5% for targets and normal organs, respectively.
  • The PTS process is efficient, completing plan transfers in under 10 minutes versus the 2 hours typically required for manual duplication, and the resulting plans are generally considered acceptable for treatment without needing further validation.

Article Abstract

The purpose of this work is to evaluate statistically the accuracy of a patient transfer station (PTS, TomoTherapy Inc., Madison, WI) that automatically converts one planning-station-generated treatment plan to another one with a different beam model. In our department we have installed 2 HI*ART tomotherapy systems, and patients often need to be transferred from one tomotherapy unit to the other. Thirty patients who underwent patient transfer between the two systems were evaluated. For each patient, dose differences between his/her original plan and PTS-transferred plan were evaluated by comparing doses at 10 randomly selected positions in his/her CT images. The Pearson indexes were calculated to analyze the relationship of the deviations to other parameters, which include absolute dose levels, sites (targets or normal tissues), dose accuracy of original plans and that of transferred plans. The dose accuracy of a treatment plan was determined by comparing delivered doses at the center of a 30 cm x 30 cm x 12 cm solid water phantom to planned doses at the same position. The calculated dose difference between original and transferred plans was, on average, 0.8% +/- 0.5%; the maximum deviation in absolute values was 1.9% in target volumes and 2.5% in normal organs. The errors generated during PTS-based transferring process were random and did not show correlation with other parameters. The PTS took less than 10 minutes to generate a backup plan that is much less than 2 hours that is approximately needed to create a duplicate plan manually. The results show that a PTS-transferred plan is an acceptable match to the original plan. With a physician's approval, a transferred plan is acceptable for treatment without the necessity of being revalidated in phantom. Thus far, all of our PTS plans have been approved by the treating physician without further optimization.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720552PMC
http://dx.doi.org/10.1120/jacmp.v10i3.3060DOI Listing

Publication Analysis

Top Keywords

patient transfer
12
plan
9
transfer station
8
treatment plan
8
original plan
8
pts-transferred plan
8
dose accuracy
8
transferred plans
8
plan acceptable
8
dose
5

Similar Publications

Background: Nosocomial outbreaks with multidrug-resistant bacteria with a probable reservoir in hospital toilets and drainage systems have been increasingly reported.

Aim: To investigate an increase in bacteraemia with extended-spectrum β-lactamase (ESBL)-producing at our hospital in 2021; the epidemiology of the outbreak suggested an environmental source.

Methods: Available clinical isolates from patient with infection or rectal carriage from 2019 to 2022 were collected.

View Article and Find Full Text PDF

Pf bacteriophages, lysogenic viruses that infect are implicated in the pathogenesis of chronic infections; phage-infected (Pf+) strains are known to predominate in people with cystic fibrosis (pwCF) who are older and have more severe disease. However, the transmission patterns of Pf underlying the progressive dominance of Pf+ strains are unclear. In particular, it is unknown whether phage transmission commonly occurs horizontally between bacteria within the airway via viral particles or if Pf+ bacteria are mostly acquired via new infections.

View Article and Find Full Text PDF

Conventional personal health record (PHR) management systems are centralized, making them vulnerable to privacy breaches and single points of failure. Despite progress in standardizing healthcare data with the FHIR format, hospitals often lack efficient platforms for transferring PHRs, leading to redundant tests and delayed treatments. To address these challenges, we propose a decentralized PHR management system leveraging Personal Data Stores (PDS) and Decentralized Identifiers (DIDs) in line with the Web 3.

View Article and Find Full Text PDF

Cancer-associated fibroblast-derived exosomal FAM83F regulates KIF23 expression to promote the malignant progression and reduce radiosensitivity in non-small cell lung cancer.

Cytotechnology

April 2025

Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing Cancer Institute, Chongqing Cancer Hospital, Chongqing University Cancer Hospital, Chongqing, 400030 China.

Unlabelled: Cancer-associated fibroblasts (CAFs) have been shown to play a crucial role in the progression of non-small cell lung cancer (NSCLC). Exosomes derived from CAFs have emerged as important mediators of intercellular communication in the tumor microenvironment, contributing to cancer progression. Therefore, it is essential to further investigate the mechanisms by which CAF-derived exosomes regulate NSCLC.

View Article and Find Full Text PDF

Recent Developments in Ventricular Assist Device Therapy.

Rev Cardiovasc Med

January 2025

Center for Preclinical Surgical & Interventional Research, The Texas Heart Institute, Houston, TX 77030, USA.

The evolution of left ventricular assist devices (LVADs) from large, pulsatile systems to compact, continuous-flow pumps has significantly improved implantation outcomes and patient mobility. Minimally invasive surgical techniques have emerged that offer reduced morbidity and enhanced recovery for LVAD recipients. Innovations in wireless power transfer technologies aim to mitigate driveline-related complications, enhancing patient safety and quality of life.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!